<DOC>
	<DOCNO>NCT01583621</DOCNO>
	<brief_summary>Primary Specific Aim 1 : To compare dose-responsive effect vitamin D3 supplementation 25 ( OH ) D , parathyroid hormone ( PTH ) , serum/urine calcium . Primary Specific Aim 2 : To compare dose-responsive effect vitamin D3 supplementation non-invasive vascular measure include pulse wave velocity ( PWV ) , flow-mediated dilation ( FMD ) , carotid arterial compliance ( CAC ) , carotid Intima-Media Thickness ( cIMT ) , 24-hours Ambulatory Blood Pressure ( ABP ) monitoring well casual BP .</brief_summary>
	<brief_title>Vitamin D Supplementation Overweight/Obese African American Adults Youth ( D-SUNNY )</brief_title>
	<detailed_description />
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>1 . AfricanAmericans ( black ) 2 . Age 1345 3 . Overweight/obese ( BMI ≥ 85th percentile age gender age 1317 BMI ≥ 25 kg/m2 age 1845 ) 4 . Relatively healthy ( medical history heart , lung , endocrine malignant disorder ) 5 . Non pregnant 6 . Not medication vitamin supplement influence study outcomes 7 . Serum 25 hydroxy Vitamin D ( 25 [ OH ] D ) level ≤ 20 ng/ml ( 50 nmol/L ) time screen 1 . Not meet one criterion 2 . Females become pregnant/test positive urine pregnancy test screen test visit 3 . Anyone take multivitamin supplement contain vitamin D</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>